6585 RESULTS
Sort By:
Vancouver Frontotemporal Dementia Conference Shows Awakening Field First Data from GENFI1: Brain’s Insula Region Shrinks A Decade Before FTD German Network of 700 FTLD Patients Presents Baseline Data Meet the Artful Leftie: NIH Jump-Starts U.S.-Canadian F
Primates tolerate treatment with bispecific antibodies that smuggle anti-BACE1 across the blood-brain barrier.
Standardized scale to harmonize results from different imaging strategies.
Researchers claim basic conclusions still sound.
Term covers tauopathy in the absence of Aβ, regardless of cognitive state.
Trophic factor may rejuvenate aging cells and protect neurons.
Researchers detect aberrant methylation in genome regions that associate with late-onset AD.
Confirming hints from case reports, the Genetic FTD Initiative, a European-Canadian frontotemporal dementia network, shows which brain areas change long before tau, progranulin, and C9ORF72 mutation carriers become symptomatic.
Not to be outdone by ongoing FTLD cohort studies underway mostly in Europe, U.S.-Canadian studies are now forging structured networks to track presymptomatic and symptomatic cases and to engage a panoply of funders and advocacy groups in a clinical trials initiative.
You might not think it possible to assemble large, longitudinal cohorts of loyal study subjects for rare dementias marked by apathy and emotional blunting. Think again—at the International Conference for Frontotemporal Dementia, researchers showed that they just did it.
FORUM Pharmaceuticals announced that its histone deacetylase inhibitor has passed a Phase 1 trial, and will advance to Phase 2 immediately. It was one of two trials presenting data on active investigational drugs at ICFTD.
In a two-year study, a heaping dose of vitamin B did nothing to sharpen cognition in people over 65, casting further doubt on the supplement’s ability to stave off dementia.
Variants in the genome that increase the risk for Alzheimer’s also lower the age of onset.
In debating how C9ORF72 causes neurodegeneration, researchers struggle to connect cell-culture results with divergent patterns of human disease.
At ICFTD, researchers proposed new genes and explored genetic differences that contribute to the vast diversity of FTD clinical presentations.
No filters selected
